Dublin – Ireland is focussing on expanding productivity in the upstream processing of biological drugs. Science Minister Conor Lenihan has announced EUR2.3m in funding for the next 3 years aimed at delivering more efficient and cheaper processes in manufacturing biologicals. The industry-led programme involves 15 biopharmaceutical companies – seven of them Irish – the universities in Dublin and Cork, and ABB Ireland. Research is aimed at the development of methods that enable continuous analyses of running processes. Currently such quality control is carried out only after a batch has been harvested.